InVivo Therapeutics Holdings Corp (NVIVQ)

[Pemmanuel]

Ddo, there are many biotechs and Pharmas within only 14 months of approval that are increasing in value and are certainly not seen as "dead" due to steadily increasing accumulation before future value kicks in. If you are a day trader it may look like "dead money" to you but not to other kinds of investors, especially at this current under valuation. The company already has the means to produce hundreds of scaffolds in house. Obviously they are saying they will need a contract manufacturer for when demand is in the thousands, hence the remarks. There has been several analyst and company projections in the past, putting the demand into the numerical range that I cited. That range correlates to annual thoracic complete SCI. Doctors could possibly even exceed that by going off label on similar related injuries. Then there is a ROW factor which is additive. But I don't think it will take much time to ascend to the range of thoracic AIS-A injuries because the ONLY FDA-approved intervention will rapidly fill the vacuum and become the new standard of care. Surgeons will be remiss not to employ a new proven and FDA approved technique that might triple the odds of recovery from acute complete paralysis.